Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000426262 | SCV000520909 | pathogenic | not provided | 2023-05-30 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26598494, 24892788, 24847886, 19630075, 26350204, 32247176, 31440721, 25564316) |
Labcorp Genetics |
RCV000705009 | SCV000833986 | pathogenic | GLUT1 deficiency syndrome 1, autosomal recessive | 2024-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 92 of the SLC2A1 protein (p.Arg92Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with PED and paroxysmal kinesigenic dyskinesia (PKD) and paroxysmal exercise-induced dyskinesia (PED) and GLUT1 deficiency syndrome (PMID: 19630075, 25564316, 26598494). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 16119). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. |
Raymond Lab, |
RCV000850197 | SCV000897734 | likely pathogenic | Intellectual disability | 2019-02-13 | criteria provided, single submitter | research | |
Department of Genetics, |
RCV001843456 | SCV002102858 | likely pathogenic | Developmental disorder | 2021-11-19 | criteria provided, single submitter | clinical testing | |
Laboratory of Human Genetics, |
RCV002243647 | SCV002512189 | pathogenic | Encephalopathy due to GLUT1 deficiency; Childhood onset GLUT1 deficiency syndrome 2 | 2022-05-13 | criteria provided, single submitter | research | This variant meets our criteria to be classified as pathogenic based upon segregation studies, extremely low frequency, and in-silico evaluation of pathogenicity. |
Genome- |
RCV003445077 | SCV004173571 | likely pathogenic | Encephalopathy due to GLUT1 deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000426262 | SCV004700062 | pathogenic | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | SLC2A1: PP1:Strong, PS2, PM2, PS4:Moderate, PP3 |
OMIM | RCV000017499 | SCV000037771 | pathogenic | Childhood onset GLUT1 deficiency syndrome 2 | 2009-08-15 | no assertion criteria provided | literature only | |
Genome Diagnostics Laboratory, |
RCV000426262 | SCV001927836 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000426262 | SCV001952704 | pathogenic | not provided | no assertion criteria provided | clinical testing |